糖心原创

Centre for Applied Bioethics
 

Image of Cinzia Allegrucci

Cinzia Allegrucci

Professor of Cancer Cell Biology, Faculty of Medicine & Health Sciences

Contact

Biography

I graduated in Chemistry and Pharmaceutical Technologies at the University of Perugia (Italy) in 1995. I obtained my PharmD (EU-qualified) in 1996 and PhD (Cum Laude) in Biochemistry from the University of Perugia (Italy) in 2001. I spent two years (2001-2003) as Post-doctoral Fellow at the School of Biosciences (糖心原创) and was then appointed as Senior Research Fellow at the School of Human Development (糖心原创) for the following four years. In 2007 I joined the Institute of Genetics and spin-out company EvoCell Ltd (糖心原创) as Senior Research Fellow. In 2009 I started my academic appointment at the 糖心原创 and I am currently Professor in Cancer Cell Biology. I am an executive member of the Nottingham Breast Cancer Research Centre and hold a professional membership with the UK General Pharmaceutical Council.

Expertise Summary

Dr Cinzia Allegrucci is Professor in Cancer Cell Biology

Dr Allegrucci is an executive member of the Nottingham Breast Cancer Research Centre (NBCRC)

/research/groups/nottinghambreastcancerresearchcentre/index.aspx

Dr Allegrucci is a member of the Nottingham Centre for Cancer Sciences.

/ccs/

Dr Allegrucci is a pharmacist registered with the General Pharmaceutical Council (GPhC reg. number 2206010)

Expertise key words: epigenetics, stem cells, cancer stem cells, germ cells, reprogramming, cancer biology

Teaching Summary

I convene the Oncology module. I teach first, second and third year undergraduate students in the subjects of cell biology, molecular biology, genetics, oncology. I am a coordinator of the School… read more

Research Summary

My research interests are in Epigenetics and Stem Cell Biology. We are working to understand how stem cells are epigenetically regulated during normal tissue homeostasis and in disease. The answer to… read more

Recent Publications

  • GHANNAM, S. F., RUTLAND, C. S., ALLEGRUCCI, C., MATHER, M. L., ALSALEEM, M., BATEMAN-PRICE, T. D., PATKE, R., BALL, G., MONGAN, N. P. and RAKHA, E., 2025. J Microsc. 297(2), 135-152
  • CROWLEY, D., SIMPSON, L., CHATFIELD, J., FOREY, T., ALLEGRUCCI, C., SANG, F., HOLMES, N., GENIKHOVICH, G., TECHNAU, U., CUNNINGHAM, D., SILVA, E., MULLIN, N., DIXON, J. E., LOOSE, M., ALBERIO, R. and JOHNSON, A. D., 2025. Cell Rep. 44(3), 115396
  • HARRIS, A. E., LOTHION-ROY, J., THOMPSON, R. L., HAQUE, M., WOODCOCK, C. L., ALSALEEM, M. A., DEAN, A., KARIRI, Y., TOSS, M. S., GUDAS, L. J., GREEN, A. R., ALLEGRUCCI, C., DAVIS, M. B., IRSHAD, S., PARK, K. H., MADHUSUDAN, S., FRAY, R. G., JEYAPALAN, J. N., RUTLAND, C. S., RAKHA, E. A. and MONGAN, N. P., 2025. NPJ breast cancer.
  • BROWN,THOMAS J., RUTLAND,CATRIN S., CHOI,KATIE K., TSE,FENG, PEFFERS,MANDY J., MONGAN,NIGEL P., ARKILL,KENTON P., RITCHIE,ALISON, CLARKE,PHILIP A., RATAN,HARI, ALLEGRUCCI,CINZIA, GRABOWSKA,ANNA M. and JAMES,VICTORIA, 2024. Frontiers in Cell and Developmental Biology. 12,

Applications for a PhD position are invited all year round from exceptional graduates to study epigenetic mechanisms involved in carcinogenesis and tumour reversion. Our lab is interested in understanding the epigenetic mechanisms involved in carcinogenesis. Gene function is regulated by epigenetic remodelling of chromatin via DNA methylation, histone modification and RNA interference. These epigenetic modifications play a fundamental role during development and are altered in cancer. A fundamental question in cancer research is the identification of molecular mechanisms that initiate and sustain tumour growth. We are studying how altered epigenetic regulation of gene function can transform tissue stem cells and/or somatic cells to cancer stem cells. We are also investigating how cancer-associated epigenetic alterations can be reverted by cellular reprogramming. To this end, we use e induced pluripotent stem cell (iPSC) technology to study how epigenetic alterations can be erased from cancer cells.

Applications for a PhD position are invited all year round from exceptional graduates to study the gene networks involved in germ cell development and cancer.

Our lab is studying the gene networks involved in primordial germ cell (precursors of gametes) specification during embryo development and how these genes become mis-regulated in germ cell tumors. The project uses embryonic stem cells, induced pluripotent stem cells (iPSC), teratocarcinoma cells and human patient tumours models.

Funding Notes:

Candidates interested in joining our lab to work in these research areas can contact Dr Allegrucci by sending an e-mail to cinzia.allegrucci@nottingham.ac.uk Position are currently available only to self-funded students.

I convene the Oncology module. I teach first, second and third year undergraduate students in the subjects of cell biology, molecular biology, genetics, oncology. I am a coordinator of the School Interprofessional Education Program.

Current Research

My research interests are in Epigenetics and Stem Cell Biology. We are working to understand how stem cells are epigenetically regulated during normal tissue homeostasis and in disease. The answer to this biological question is fundamental to understand the basis of human diseases characterised by a stem cell dysfunction and for the development of stem cell therapies.

Epigenetic alterations in carcinogenesis

The epigenetic regulation of DNA function is achieved by chromatin remodelling via DNA methylation and histone modifications and RNA interference. These epigenetic modifications play a fundamental role in development and disease. A fundamental question in cancer research is the identification of molecular mechanisms that initiate and sustain tumour growth. The recent identification of stem cells that initiate and sustain tumour growth (cancer stem cells) is opening a new promise for the understanding of tumorigenesis and for the development of novel diagnostic and therapeutic strategies targeted specifically to tumour-initiating cells. My research group is investigating the epigenetic events that initiate breast cancer formation and how they cooperate with genetic alterations in cancer progression.

Epigenetic reprogramming of cancer cells

Altered epigenetic regulation of the genome is associated with tumour initiation and progression. Genome-wide DNA hypomethylation and hypermethylation of tumour suppressor genes are hallmark of cancer. Our Lab is focussing on dissecting the epigenetic mechanisms of tumorigenesis by using induced pluripotent stem cell (iPSC) technologies to epigenetically reprogram cancer cells and establish advanced disease organoid models.

Pluripotent stem cells and germ cell tumours

Our laboratory is investigating the molecular mechanisms regulating pluripotency and primordial germ cell specification. We are interested in the molecular mechanisms regulating germ cell differentiation and the formation off germ cell tumours. We use embryonic stem cells, teratocarcinoma cells and induced pluripotent stem cells to address these questions.

Funding

BBSRC, NC3Rs, Animal Free Research UK

Present Lab Members

Riba Thomas

Tinyiko Modikoane

Nabeelah Almalki

Past Lab Members

Mercedes Vasquez Cantu. Project: Stem cell-derived organoids model of breast cancer. Current position: Post-doctoral researcher, 糖心原创

Ahmed Alnaeem. Project: Synthetic nanoparticles for drug delivery in cancer. Current position: Lecturer, Saudi Arabia

Ahmad Zyoud. Project: PIWI RNA in cancer. Current position: Senior scientist at Wobble Genomics.

Megan Wilde. Project: Novel breast cancer antigens for targeted therapies. Current position: Medical Writer at Porterhouse Medical.

Leong Yeh Chwan. project: Epigentic reprogramming of cancer cells. Current position: Senior Scientistsat Vertex.

Ryan Cardenas. Project: Pluripotency gene networks in germ cell homeostasis. Current position: CS genetics.

Norazalina Saad. Project: Epigenetic reprogramming of breast cancer cells. Current position:Lecturer, Laboratory of Cancer Research, University Putra Malaysia.

Mansi Shah. Project: Role of homeobox genes in breast cancer stem cells. Current position: Senior technical specilist. University College London.

Somsin Petyim. Project: Germ cell differentiation from pluripotent stem cells. Current position: Associate Professor, MD, PhD, Mahidol University, Thailand.

  • GHANNAM, S. F., RUTLAND, C. S., ALLEGRUCCI, C., MATHER, M. L., ALSALEEM, M., BATEMAN-PRICE, T. D., PATKE, R., BALL, G., MONGAN, N. P. and RAKHA, E., 2025. J Microsc. 297(2), 135-152
  • CROWLEY, D., SIMPSON, L., CHATFIELD, J., FOREY, T., ALLEGRUCCI, C., SANG, F., HOLMES, N., GENIKHOVICH, G., TECHNAU, U., CUNNINGHAM, D., SILVA, E., MULLIN, N., DIXON, J. E., LOOSE, M., ALBERIO, R. and JOHNSON, A. D., 2025. Cell Rep. 44(3), 115396
  • HARRIS, A. E., LOTHION-ROY, J., THOMPSON, R. L., HAQUE, M., WOODCOCK, C. L., ALSALEEM, M. A., DEAN, A., KARIRI, Y., TOSS, M. S., GUDAS, L. J., GREEN, A. R., ALLEGRUCCI, C., DAVIS, M. B., IRSHAD, S., PARK, K. H., MADHUSUDAN, S., FRAY, R. G., JEYAPALAN, J. N., RUTLAND, C. S., RAKHA, E. A. and MONGAN, N. P., 2025. NPJ breast cancer.
  • BROWN,THOMAS J., RUTLAND,CATRIN S., CHOI,KATIE K., TSE,FENG, PEFFERS,MANDY J., MONGAN,NIGEL P., ARKILL,KENTON P., RITCHIE,ALISON, CLARKE,PHILIP A., RATAN,HARI, ALLEGRUCCI,CINZIA, GRABOWSKA,ANNA M. and JAMES,VICTORIA, 2024. Frontiers in Cell and Developmental Biology. 12,
  • BROWN, T. J., RUTLAND, C. S., CHOI, K. K., TSE, F., PEFFERS, M. J., MONGAN, N. P., ARKILL, K. P., RITCHIE, A., CLARKE, P. A., RATAN, H., ALLEGRUCCI, C., GRABOWSKA, A. M. and JAMES, V., 2024. Front Cell Dev Biol. 12, 1354606
  • PATKE, R., HARRIS, A. E., WOODCOCK, C. L., THOMPSON, R., SANTOS, R., KUMARI, A., ALLEGRUCCI, C., ARCHER, N., GUDAS, L. J., ROBINSON, B. D., PERSSON, J. L., FRAY, R., JEYAPALAN, J., RUTLAND, C. S., RAKHA, E., MADHUSUDAN, S., EMES, R. D., MUYANGWA-SEMENOVA, M., ALSALEEM, M., DE BROT, S., GREEN, W., RATAN, H., MONGAN, N. P. and LOTHION-ROY, J., 2024. Neoplasia. 56, 101032
  • CARDENAS, R. P., ZYOUD, A., MCINTYRE, A., ALBERIO, R., MONGAN, N. P. and ALLEGRUCCI, C., 2024. Stem Cell Res Ther. 15(1), 128
  • LOTHION-ROY, JENNIFER, HAIGH, DAISY B., HARRIS, ANNA E., METZLER, VERONIKA M., ALSALEEM, MANSOUR, TOSS, MICHAEL S., KARIRI, YOUSIF, NTEKIM, ATARA, ROBINSON, BRIAN D., KHANI, FRANCESCA, GUDAS, LORRAINE J., ALLEGRUCCI, CINZIA, JAMES, VICTORIA H., MADHUSUDAN, SRINIVASAN, MATHER, MELISSA, EMES, RICHARD D., ARCHER, NATHAN, FRAY, RUPERT G., RAKHA, EMAD, JEYAPALAN, JENNIE N., RUTLAND, CATRIN S., MONGAN, NIGEL P. and WOODCOCK, CORINNE L., 2023. Clinical and molecular significance of the RNA m(6)A methyltransferase complex in prostate cancer FRONTIERS IN GENETICS. 13,
  • GHANNAM, S. F., RUTLAND, C. S., ALLEGRUCCI, C., MONGAN, N. P. and RAKHA, E., 2023. Histopathology. 83(3), 376-393
  • ATALLAH, N. M., HAQUE, M., QUINN, C., TOSS, M. S., MAKHLOUF, S., IBRAHIM, A., GREEN, A. R., ALSALEEM, M., RUTLAND, C. S., ALLEGRUCCI, C., MONGAN, N. P. and RAKHA, E., 2023. Eur J Cancer. 195, 113371
  • PONOMAREV, A, GILAZIEVA, Z, SOLOVYEVA, V, ALLEGRUCCI, C and RIZVANOV, A, 2022. Cancers. 14, 970
  • IDRISOVA, K.F, ZEINALOVA, A.K, MASGUTOVA, G.A, BOGOV, A.A., ALLEGRUCCI, C, SYROMIATNIKOVA, V,Y, GARANINA, E.E, GARANINA, E.E, ANDREEVA,D.I, KADYROV, A.A, RIZVANOV, A.A and MASGUTOV, R.F, 2022. Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury Neural. Regen. Res.. 17, 1240-1247
  • HARRIS, ANNA E., METZLER, VERONIKA M., LOTHION-ROY, JENNIFER, VARUN, DHRUVIKA, WOODCOCK, CORINNE L., HAIGH, DAISY B., ENDELEY, CHANTELLE, HAQUE, MARIA, TOSS, MICHAEL S., ALSALEEM, MANSOUR, PERSSON, JENNY L., GUDAS, LORRAINE J., RAKHA, EMAD, ROBINSON, BRIAN D., KHANI, FRANCESCA, MARTIN, LAURA M., MOYER, JENNA E., BROWNLIE, JULIETTE, MADHUSUDAN, SRINIVASAN, ALLEGRUCCI, CINZIA, JAMES, VICTORIA H., RUTLAND, CATRIN S., FRAY, RUPERT G., NTEKIM, ATARA, DE BROT, SIMONE, MONGAN, NIGEL P. and JEYAPALAN, JENNIE N., 2022. Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer FRONTIERS IN ENDOCRINOLOGY. 13,
  • GHANNAM, SUZAN F., RUTLAND, CATRIN SIAN, ALLEGRUCCI, CINZIA, MONGAN, NIGEL P. and RAKHA, EMAD, 2022. Defining invasion in breast cancer: the role of basement membrane JOURNAL OF CLINICAL PATHOLOGY.
  • MAHMOUD, RINAD, ORDONEZ-MORAN, PALOMA and ALLEGRUCCI, CINZIA, 2022. Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness CANCERS. 14(17),
  • PAL A, ASHWORTH JC, COLLIER P, PROBERT C, JONES S, LEZA EP, MEAKIN ML, A RITCHIE A, ONION D, CLARKE PA, ALLEGRUCCI C and GRABOWSKA AM, 2020. Cancers. 12(8),
  • SIMPSON, SIOBHAN, DUNNING, MARK, DE BROT, SIMONE, ALIBHAI, AZIZA, BAILEY, CLARA, WOODCOCK, CORINNE L, MESTAS, MADELINE, AKHTAR, SHAREEN, JEYAPALAN, JENNIE N, LOTHION-ROY, JENNIFER, EMES, RICHARD D, ALLEGRUCCI, CINZIA, RIZVANOV, ALBERT A, MONGAN, NIGEL P and RUTLAND, CATRIN S, 2020. Cancers. 12(9),
  • MASGUTOV, RUSLAN, MASGUTOVA, GALINA, MULLAKHMETOVA, ADELYA, ZHURAVLEVA, MARGARITA, SHULMAN, ANNA, ROGOZHIN, ALEXANDER, SYROMIATNIKOVA, VALERIYA, ANDREEVA, DINA, ZEINALOVA, ALINA, IDRISOVA, KAMILLA, ALLEGRUCCI, CINZIA, KIYASOV, ANDREY and RIZVANOV, ALBERT, 2019. FRONTIERS IN MEDICINE. 6,
  • SMITH, JESSICA, ZYOUD, AHMAD and ALLEGRUCCI, CINZIA, 2019. Cancers. 11(4),
  • SAAD N, ALBERIO R, JOHNSON AD, EMES RD, GILES TC, CLARKE P, GRABOWSKA AM and ALLEGRUCCI C, 2018. Oncotarget. 9(22), 16008-16027
  • SHAH M, CARDENAS R, WANG B, PERSSON J, MONGAN NP, GRABOWSKA A and ALLEGRUCCI C, 2017. Molecular cancer. 16(1), 38
  • METZLER VM, DE BROT S, ROBINSON RS, JEYAPALAN JN, RAKHA E, WALTON T, GARDNER DS, LUND EF, WHITCHURCH J, HAIGH D, LOCHRAY JM, ROBINSON BD, ALLEGRUCCI C, FRAY RG, PERSSON JL, 脴DUM N, MIFTAKHOVA RR, RIZVANOV AA, HUGHES IA, TADOKORO-CUCCARO R, HEERY DM, RUTLAND CS and MONGAN NP, 2017. Placenta. S0143-4004(17), 30164-9
  • KOBAYASHI T, ZHANG H, TANG WWC, IRIE N, WITHEY S, KLISCH D, SYBIRNA A, DIETMANN S, CONTRERAS DA, WEBB R, ALLEGRUCCI C, ALBERIO R and SURANI MA, 2017. Nature. 546(7658), doi:10.1038/nature22812
  • MIFTAKHOVA, R., HEDBLOM, A., SEMENAS, J., ROBINSON, B. D., SIMOULIS, A., MALM, J., RIZVANOV, A., DAVID HEERY, D., MONGAN, N. P., MAITLAND, N. J., ALLEGRUCCI, C. and PERSSON, J. L., 2016. Cancer Res. 76(8), 2453-64
  • DE BROT, SIMONE, NTEKIM, ATARA, CARDENAS, RYAN, JAMES, VICTORIA, ALLEGRUCCI, CINZIA, HEERY, DAVID M., BATES, DAVID O., ODUM, NIELS, PERSSON, JENNY L. and MONGAN, NIGEL P., 2015. ENDOCRINE-RELATED CANCER. 22(3), R107-R123
  • WALSH M, FAIS S, SPUGNINI EP, HARGUINDEY S, ABU IZNEID T, SCACCO L, WILLIAMS P, ALLEGRUCCI C, RAUCH C and OMRAN Z, 2015. Journal of experimental & clinical cancer research. 34(1), 93
  • SHAH M and ALLEGRUCCI C, 2013. Sub-cellular biochemistry. 61, 545-565
  • MARCINKIEWICZ K, SCOTLAND KB, BOORJIAN SA, NILSSON EM, PERSSON JL, ABRAHAMSSON PA, ALLEGRUCCI C, HUGHES IA, GUDAS LJ and MONGAN NP, 2012. International Journal Of Oncology. 40(1), 5-12
  • SEMENAS J, ALLEGRUCCI C, BOORJIAN SA, MONGAN NP and PERSSON JL, 2012. Current drug targets. 13(10), 1308-2
  • MANSI SHAH and CINZIA ALLEGRUCCI, 2012. Keeping an open mind: highlights and controversies of the breast cancer stem cell theory Breast Cancer: Targets and Therapy. 4, 155-166
  • RODR脥GUEZ, A., ALLEGRUCCI, C. and ALBERIO, R., 2012. PLoS ONE. 7(11), e49079
  • ALLEGRUCCI, C., RUSHTON, M.D., DIXON, J.E., SOTTILE, V., SHAH, M., KUMARI, R., WATSON, S., ALBERIO, R. and JOHNSON, A.D., 2011. Molecular Cancer. 10(1), 7
  • DIXON, J.E., ALLEGRUCCI, C., REDWOOD, C., KUMP, K., BIAN, Y., CHATFIELD, J., CHEN, Y.-H., SOTTILE, V., VOSS, S.R., ALBERIO, R. and JOHNSON, A.D., 2010. Development. 137(18), 2973-2980
  • ALBERIO, R., CROXALL, N. and ALLEGRUCCI, C., 2010. Stem Cells and Development. 19(10), 1627-36
  • PRIDDLE, H, ALLEGRUCCI, C, BURRIDGE, P, MUNOZ, M, SMITH, NM, DEVLIN, L, SJOBLOM, C, CHAMBERLAIN, S, WATSON, S, YOUNG, LE and DENNING, C, 2010. In Vitro Cellular & Developmental Biology-Animal. 46(3-4), 367-375
  • BIAN, Y., ALBERIO, R., ALLEGRUCCI, C., CAMPBELL, K.H. and JOHNSON, A.D., 2009. Epigenetics. 4(3), 194-202
  • ALLEGRUCCI, C., WU, Y-Z., THURSTON, A., DENNING, C.N., PRIDDLE, H., MUMMERY, C.L., WARD-VAN OOSTWAARD, D., ANDREWS, P.W., STOJKOVIC, M., SMITH, N., PARKIN, T., EDMONDSON-JONES, M., WARREN, G., YU, L., BRENA, R.M., PLASS, C. and YOUNG, L.E., 2007. Human Molecular Genetics. 16(10), 1253-1268
  • SINCLAIR, KEVIN D, ALLEGRUCCI, CINZIA, SINGH, RAVINDER, GARDNER, DAVID S, SEBASTIAN, SONIA, BISPHAM, JAYSON, THURSTON, ALEXANDRA, HUNTLEY, JOHN F, REES, WILLIAM D, MALONEY, CHRISTOPHER A and LEA, RICHARD, 2007. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proceedings of the National Academy of Sciences of the United States of America. 104(49), 19351-6
  • ALLEGRUCCI, C and YOUNG, LE, 2007. Differences between human embryonic stem cell lines. Human Reproduction Update. 16(10), 1253-68
  • KIM, KEE-PYO, THURSTON, ALEXANDRA, MUMMERY, CHRISTINE, WARD-VAN OOSTWAARD, DORIEN, PRIDDLE, HELEN, ALLEGRUCCI, CINZIA, DENNING, CHRIS and YOUNG, LORRAINE, 2007. Genome Research. 17(12), 1731-42
  • THURSTON, A, LUCAS, E S, ALLEGRUCCI, C, STEELE, W and YOUNG, L E, 2007. Theriogenology. 68 Suppl 1, S98-106
  • BURRIDGE, P.W., ANDERSON, D., PRIDDLE, H., BARBADILLO MU脩OZ, M.D.B., CHAMBERLAIN, S., ALLEGRUCCI, C., YOUNG, L.E. and DENNING, C., 2006. Stem Cells. 24(4), 929-938
  • DENNING, C., ALLEGRUCCI, C., PRIDDLE, H., BARBADILLO-MU脩OZ, M.D., ANDERSON, D., SELF, T., SMITH, N.M., PARKIN, C.T. and YOUNG, L.E., 2006. International Journal of Developmental Biology. 50(1), 27-37
  • STEELE, W, ALLEGRUCCI, C, SINGH, R, LUCAS, E, PRIDDLE, H, DENNING, C, SINCLAIR, K and YOUNG, L, 2005. Reproductive Biomedicine online. 10(6), 755-66
  • ALLEGRUCCI, C., DENNING, C.N., BURRIDGE, P., STEELE, W., SINCLAIR, K.D. and YOUNG, L.E., 2005. Reproductive Toxicology. 20(3), 353-367
  • ALLEGRUCCI, C, THURSTON, A, LUCAS, E and YOUNG, L, 2005. Reproduction. 129(2), 137-49
  • ALLEGRUCCI, C., DENNING, C., PRIDDLE, H. and YOUNG, L., 2004. Lancet. 364(9429), 206-208
  • ALLEGRUCCI, C, HUNTER, M G, WEBB, R and LUCK, M R, 2003. Reproduction. 126(4), 527-38
  • MINELLI, A., ALLEGRUCCI, C., LIGUORI, L. and RONQUIST, G., 2002. The Prostate. 51(1), 1-9
  • ALLEGRUCCI, C. and LARSSON, A., 2002. Prostasomes are antigens for naturally occurring antisperm antibodies. In: RONQUIST, G, ed., Prostasomes 81. Portland Press, Colchester.
  • ALLEGRUCCI, C., LIGUORI, L. and MINELLI, A., 2001. Biology of Reproduction. 64(6), 1653-1659
  • ALLEGRUCCI, C., RONQUIST, G., OVE NILSSON, B., CARLSSON, L., LUNDQVIST, M., MINELLI, A. and LARSSON, A, 2001. American Journal of Reproductive Immunology. 46(3), 211-219
  • ALLEGRUCCI, C, LIGUORI, L, MEZZASOMA, I and MINELLI, A, 2000. Molecular genetics and metabolism. 71(1-2), 381-6
  • MINELLI, A, ALLEGRUCCI, C, PIOMBONI, P, MANNUCCI, R, LLUIS, C and FRANCO, R, 2000. Journal of Histochemistry and Cytochemistry. 48(9), 1163-71
  • MINELLI, A, ALLEGRUCCI, C, ROSATI, R and MEZZASOMA, I, 2000. Molecular Reproduction and Development. 56(4), 527-33
  • MINELLI, A, ALLEGRUCCI, C, MEZZASOMA, I, RONQUIST, G, LLUIS, C and FRANCO, R, 1999. Biology of Reproduction. 61(3), 802-8
  • MINELLI, A, ALLEGRUCCI, C, ROSATI, R and MEZZASOMA, I, 1998. Molecular genetics and metabolism. 63(3), 183-90
  • MINELLI, A, MISCETTI, P, ALLEGRUCCI, C and MEZZASOMA, I, 1995. Archives of Biochemistry and Biophysics. 322(1), 272-6

Centre for Applied Bioethics

The 糖心原创
School of Veterinary Medicine and Science
Sutton Bonington Campus, Leicestershire, LE12 5RD


telephone: +44 (0) 115 951 6116
email: Email our Research Theme Leader